Remove 2007 Remove Drugs Remove Testimonials
article thumbnail

Fatty Liver Case Study cb | Blue Heron Health News

The Pharma Data

According to the Centre for Disease Control and Prevention, the number of deaths caused by liver disease and cirrhosis has risen every year since 2007. There are no drugs for this. Testimonial / Case Study Legal Disclaimer: The story, testimonials, and case studies discussed on this page may be unique. No tablet to take.

Doctors 52
article thumbnail

Let's Quit Sugar With Audiobook – Let's Quit Sugar

The Pharma Data

Testimonials are not necessarily representative of all of those who will use our products. Some of our testimonials are provided by customers who have received promotional offers in exchange for their participation. The testimonials displayed are given verbatim except for correction of grammatical or typing errors. 2012.11.002.

Disease 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Malarkey ? The Ten Worst Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

Speaking of cold and darkness, it is now time for us to look back upon the results of drug and medical device litigation during 2023 and to select the ten worst decisions of the year. 2023), was the Fifth Circuit’s blatantly politicized attack on the FDA’s regulation of abortion-related drugs. FDA , 78 F.4th 4th 210 (5th Cir.

article thumbnail

Guest Post – Defendant Pitches A Shut Out And Hits A Home Run In Securing Summary Judgment In A Fosamax Case

Drug & Device Law

The court exercised its “gatekeeping” function under Rule 702 to assess whether the methodology underlying Plaintiff’s proffered expert testimony was “scientifically valid” and whether it could “be [properly] applied to the facts in issue.” Nor could Plaintiff fill that void by relying on expert testimony from other cases.

article thumbnail

Taxotere Timing Troubles Persistently Plague Plaintiffs

Drug & Device Law

Specifically, plaintiffs have defined their injury as being hair loss that persists more than six months after their cessation of treatment with the defendant’s cancer chemotherapy drug. She completed her therapy in 2007, more than ten years before she filed suit – that suit having been solicited by a p-side lawyer.

article thumbnail

Guest Post – More on Expert Gatekeeping in West Virginia

Drug & Device Law

In the “ 50-State Survey of State Court Decisions Supporting Expert-Related Judicial Gatekeeping ,” the Drug & Device Law Blog (the Best Blog on the Planet) describes West Virginia as a “gatekeeper” state because of cases reflecting adoption of the Daubert analysis of W. 2007) (citation omitted). CSX Transportation, Inc. ,

article thumbnail

The FDA and Feasible Alternative Designs

Drug & Device Law

Drug manufacturers often could trade a little less efficacy for a little more safety, but the safest design is not always the best one. to determine whether a proposed alternative drug would have received FDA approval.” For physicians to prescribe such a safer drug, it must reach the market. Wyeth LLC , 562 U.S. 2d 506 (N.Y.

FDA 59